APA (7th ed.) Citation

Papantoniou, D., Fröss‐Baron, K., Garske‐Román, U., Sundin, A., Thiis‐Evensen, E., Grönberg, M., . . . Tiensuu Janson, E. (2025). Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients. Journal of Neuroendocrinology, 37(3), 1. https://doi.org/10.1111/jne.13379

Chicago Style (17th ed.) Citation

Papantoniou, Dimitrios, Katarzyna Fröss‐Baron, Ulrike Garske‐Román, Anders Sundin, Espen Thiis‐Evensen, Malin Grönberg, Staffan Welin, and Eva Tiensuu Janson. "Hypoalbuminemia, but Not Derived Neutrophil to Lymphocyte Ratio (dNLR), Predicts Overall Survival in Neuroendocrine Tumours Undergoing Peptide Receptor Radionuclide Therapy: A Retrospective, Cohort Study of 557 Patients." Journal of Neuroendocrinology 37, no. 3 (2025): 1. https://doi.org/10.1111/jne.13379.

MLA (9th ed.) Citation

Papantoniou, Dimitrios, et al. "Hypoalbuminemia, but Not Derived Neutrophil to Lymphocyte Ratio (dNLR), Predicts Overall Survival in Neuroendocrine Tumours Undergoing Peptide Receptor Radionuclide Therapy: A Retrospective, Cohort Study of 557 Patients." Journal of Neuroendocrinology, vol. 37, no. 3, 2025, p. 1, https://doi.org/10.1111/jne.13379.